inner thera bpc-157 – True Lab Peptides Innerthera Bpc-157 + Tb4-frag 500/250mcg
Description
Split dosing at 0.25 mg twice daily (morning and evening) may provide more consistent peptide exposure throughout the day

It is an experimental compound that has been investigated for inflammatory bowel disease and soft tissue healing, although there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions

Comprehensive documentation of treatment rationale, patient consent processes, and clinical monitoring should be maintained given the experimental nature of these interventions and potential regulatory scrutiny

10.1136/gutjnl-2015-311304 Gut
